ZenBio's IPO Soars 158% on First Trading Day, With Global Offering of 33.44 Million H-Shares at HK$12.90
ZenBio\'s IPO soars, with a current rise exceeding 12%, priced at HK$37.5, and yesterday\'s market performance surged 158%.
-
-
New Concepts in A-Shares Rise, Tiantan Pharmaceutical Rises Nearly 11%, Saileng Medical 10CM Halts, and Shendong Pharmaceutical, Anke Biotechnology Rises Nearly 10%
A-Shares Market New Concepts Rise, Among Which Tiantan Pharmaceutical (300255) Rises Nearly 11%, Saileng Medical 10CM Halts, and Shendong Pharmaceutical (300158), Anke Biotechnology (300009) Rises Nea -
Hong Kong Biotech Stocks Soar, North Sea Biological-B Surges 19%, Songli Biological-B Rises 15%, Asia Medical-B Up 9%, Jiayou Biological-B Increases Over 8%, Beikang Medical Up 7%
Glorious 8 August｜Hong Kong Biotech Stocks Soar, where North Sea Biological-B surges nearly 19%, Songli Biological-B rises over 15%, Asia Medical-B increases by over 9%, Jiayou Biological-B jumps -
Daily ETF Review | Shanghai Composite Index Down 0.34%, Healthcare ETF Up 2%, Infrastructure ETF and Resource ETF Both Down 2%
格隆汇7月25日｜Shanghai Composite Index Down 0.34%, Shenzhen Component Index Down 0.29%, Small Cap Index Down 0.32%, Northward50 Index Up 0.45%, Shanghai-Shenzhen-Jing three-day trading volume of RMB -
Patent Outcomes Support Plant Doctor's IPO Process, Attracting Attention
Plant Doctor\'s main board IPO application has been approved, and its deep cooperation model with research institutions has become an important guarantee for continuously improving research capabiliti